The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

PubWeight™: 4.34‹?› | Rank: Top 1%

🔗 View Article (PMID 9674618)

Published in Med Care on July 01, 1998

Authors

M S Litwin1, R D Hays, A Fink, P A Ganz, B Leake, R H Brook

Author Affiliations

1: Department of Urology, School of Medicine, University of California, Los Angeles 90095-1738, USA. mlitwin@urology.medsch.ucla.edu

Articles citing this

(truncated to the top 100)

Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med (2013) 7.95

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol (2012) 6.09

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ (2012) 4.64

Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92

Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys (2010) 3.83

Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol (2012) 3.35

Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int (2012) 2.88

A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol (2009) 2.26

Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology (2010) 2.14

Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer (2009) 2.13

The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol (2014) 2.07

Lack of comprehension of common prostate cancer terms in an underserved population. J Clin Oncol (2009) 1.82

Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. J Gen Intern Med (2004) 1.81

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol (2015) 1.74

Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol (2010) 1.60

Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol (2013) 1.58

Assessing the impact of cancer: development of a new instrument for long-term survivors. Psychooncology (2006) 1.49

Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr (2012) 1.49

Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy. J Cancer Res Clin Oncol (2009) 1.48

Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol (2003) 1.48

Using cognitive interviews to evaluate items for measuring sexual functioning across cancer populations: improvements and remaining challenges. Qual Life Res (2009) 1.46

Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer. BMC Cancer (2016) 1.43

Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. J Natl Cancer Inst (2014) 1.42

Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors. J Sex Med (2015) 1.38

Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer. J Urol (2011) 1.36

Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer (2009) 1.34

Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med (2003) 1.30

Development of the NIH PROMIS ® Sexual Function and Satisfaction measures in patients with cancer. J Sex Med (2013) 1.25

Psychological distress in spouses of men treated for early-stage prostate carcinoma. Cancer (2005) 1.22

Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397). Int J Radiat Oncol Biol Phys (2009) 1.19

The effects of dyadic strength and coping styles on psychological distress in couples faced with prostate cancer. J Behav Med (2003) 1.18

Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer. J Cancer Surviv (2009) 1.15

Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population. Urol Res (2004) 1.14

Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention. Support Care Cancer (2009) 1.13

Psychometric properties of cancer survivors' unmet needs survey. Support Care Cancer (2010) 1.10

Intimacy-enhancing psychological intervention for men diagnosed with prostate cancer and their partners: a pilot study. J Sex Med (2011) 1.08

ProsCan for Couples: randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer (2008) 1.07

Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners. Qual Life Res (2010) 0.99

Oncology professionals and patient requests for cancer support services. Support Care Cancer (2004) 0.98

Disrupted sleep in breast and prostate cancer patients undergoing radiation therapy: the role of coping processes. Psychooncology (2010) 0.96

Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer. Eur Urol (2013) 0.95

Moderators of the benefits of psychoeducational interventions for men with prostate cancer. Health Psychol (2006) 0.95

Interdependent psychological quality of life in dyads adjusting to prostate cancer. Health Psychol (2011) 0.95

Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer. J Support Oncol (2010) 0.94

Sexuality after hematopoietic stem cell transplantation. Cancer J (2009) 0.93

Dyadic concordance among prostate cancer patients and their partners and health-related quality of life: does it matter? Psychol Health (2011) 0.93

Couple distress after localised prostate cancer. Support Care Cancer (2013) 0.92

Orthotopic neobladder versus ileal conduit urinary diversion after cystectomy--a quality-of-life based comparison. Ann R Coll Surg Engl (2009) 0.91

Novel method of knotless vesicourethral anastomosis during robot-assisted radical prostatectomy: feasibility study and early outcomes in 30 patients using the interlocked barbed unidirectional V-LOC180 suture. Can Urol Assoc J (2011) 0.91

Health perceptions in patients who undergo screening and workup for prostate cancer. Urology (2007) 0.90

Promoting recovery of sexual functioning after radical prostatectomy with group-based stress management: the role of interpersonal sensitivity. J Psychosom Res (2008) 0.90

Outcomes in men denied access to a California public assistance program for prostate cancer. Public Health Rep (2007) 0.90

Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.90

Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer. Br J Cancer (2012) 0.89

Development of prostate cancer research database with the clinical data warehouse technology for direct linkage with electronic medical record system. Prostate Int (2013) 0.89

Disclosure of diagnosis and treatment among early stage prostate cancer survivors. Patient Educ Couns (2009) 0.89

Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer. Semin Radiat Oncol (2008) 0.89

Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors. Health Serv Res (2012) 0.88

Appropriate utilization of quality of life outcomes in prostate and bladder cancer: practical considerations for Brazilian Portuguese questionnaires. Clinics (Sao Paulo) (2009) 0.86

Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. BJU Int (2010) 0.86

ProsCan for men: randomised controlled trial of a decision support intervention for men with localised prostate cancer. BMC Cancer (2008) 0.85

Who benefits from a psychosocial counselling versus educational intervention to improve psychological quality of life in prostate cancer survivors? Psychol Health (2012) 0.85

The effect of ethnicity and sexual preference on prostate-cancer-related quality of life. Nat Rev Urol (2012) 0.84

The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol (2009) 0.84

Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments. Qual Life Res (2014) 0.84

Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer. BMC Cancer (2011) 0.83

The effect of erectile dysfunction on quality of life following treatment for localized prostate cancer. Rev Urol (2001) 0.83

Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: a longitudinal analysis from CaPSURE. Qual Life Res (2008) 0.83

Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer. J Radiat Res (2013) 0.83

Accuracy of 30-day recall for components of sexual function and the moderating effects of gender and mood. J Sex Med (2013) 0.82

Quality-of-life outcomes in high-risk prostate cancer patients treated with helical tomotherapy in a hypofractionated radiation schedule with long-term androgen suppression. Curr Oncol (2012) 0.82

Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification. Asian J Androl (2009) 0.81

Erection rehabilitation following prostatectomy - current strategies and future directions. Nat Rev Urol (2016) 0.81

The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer (2013) 0.81

Long-term quality of life after radical prostatectomy in wives of men in the postoperative adjuvant androgen deprivation trial. Support Care Cancer (2010) 0.80

Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res (2012) 0.80

Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int (2015) 0.80

Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study. J Urol (2011) 0.79

Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes. Patient Relat Outcome Meas (2015) 0.78

Sexual self-schema and depressive symptoms after prostate cancer. Psychooncology (2014) 0.78

The Clinician's Toolbox: Assessing the Sexual Impacts of Cancer on Adolescents and Young Adults with Cancer (AYAC). Sex Med (2015) 0.78

Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer. Rev Urol (2013) 0.78

Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus project. World J Urol (2016) 0.78

Interpreting patient-reported urinary and sexual function outcomes across multiple validated instruments. J Urol (2017) 0.77

Variations in the quality of care at radical prostatectomy. Ther Adv Urol (2012) 0.77

Quality of Life and Sexual Health in the Aging of PCa Survivors. Int J Endocrinol (2014) 0.77

Dyadic support and quality-of-life after radical prostatectomy. J Mens Health Gend (2007) 0.77

Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores? BJU Int (2011) 0.77

Validation of the German prostate-specific module. World J Urol (2006) 0.77

Holding back, intimacy, and psychological and relationship outcomes among couples coping with prostate cancer. J Fam Psychol (2015) 0.76

The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples. J Urol (2015) 0.76

Key issues affecting quality of life and patient-reported outcomes in prostate cancer: an analysis conducted in 2128 patients with initial psychometric assessment of the prostate cancer symptom scale (PCSS). BMJ Support Palliat Care (2017) 0.76

Adjustable continence therapy (ProACT™) after male sling failure for patients with post-radical prostatectomy urinary incontinence: a prospective study with one-year follow-up. World J Urol (2014) 0.76

Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients. Health Qual Life Outcomes (2016) 0.75

Cost-effectiveness of a behavioral intervention for persistent urinary incontinence in prostate cancer patients. Psychooncology (2015) 0.75

The N-shaped orthotopic ileal neobladder: functional outcomes and complication rates in 119 patients. Springerplus (2016) 0.75

Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate cancer. J Pers Assess (2012) 0.75

Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status. Investig Clin Urol (2016) 0.75

Is it worth continuing sexual rehabilitation after radical prostatectomy with intracavernous injection of alprostadil for more than 1 year? Sex Med (2015) 0.75

Oncology Section EDGE Task Force on Prostate Cancer: A Systematic Review of Outcome Measures for Health-Related Quality of Life. Rehabil Oncol (2016) 0.75

Articles by these authors

The MOS short-form general health survey. Reliability and validity in a patient population. Med Care (1988) 21.00

The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA (1989) 12.07

Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA (1989) 11.97

Consensus methods: characteristics and guidelines for use. Am J Public Health (1984) 11.53

Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol (2001) 10.35

A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98

The public release of performance data: what do we expect to gain? A review of the evidence. JAMA (2000) 9.57

The medical appropriateness of tympanostomy tubes proposed for children younger than 16 years in the United States. JAMA (1994) 7.56

Variations in the use of medical and surgical services by the Medicare population. N Engl J Med (1986) 7.26

A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care (1986) 7.26

Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA (1987) 7.04

Hospital inpatient mortality. Is it a predictor of quality? N Engl J Med (1987) 6.88

Quality-of-care assessment: choosing a method for peer review. N Engl J Med (1973) 6.82

Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med (1981) 6.76

Spinal manipulation for low-back pain. Ann Intern Med (1992) 6.69

Quality of health care. Part 2: measuring quality of care. N Engl J Med (1996) 6.46

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet (1993) 6.08

Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol (1998) 5.64

Are Latinos less satisfied with communication by health care providers? J Gen Intern Med (1999) 5.26

Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol (1993) 5.13

Does free care improve adults' health? Results from a randomized controlled trial. N Engl J Med (1983) 5.10

Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol (2000) 4.96

Effects of the National Institutes of Health Consensus Development Program on physician practice. JAMA (1987) 4.96

Termination from Medi-Cal--does it affect health? N Engl J Med (1984) 4.76

Quality-of-life outcomes in men treated for localized prostate cancer. JAMA (1995) 4.69

Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol (1984) 4.64

How good is the quality of health care in the United States? Milbank Q (1998) 4.61

Hospital characteristics and quality of care. JAMA (1992) 4.56

Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health (1986) 4.42

Methods for measuring patient satisfaction with specific medical encounters. Med Care (1988) 4.38

Comparison of health outcomes at a health maintenance organisation with those of fee-for-service care. Lancet (1986) 4.22

The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics (1999) 4.09

Variations in cataract extraction rates in Medicare prepaid and fee-for-service settings. JAMA (1997) 4.02

Congruence between decisions to initiate chiropractic spinal manipulation for low back pain and appropriateness criteria in North America. Ann Intern Med (1998) 4.01

Patients who leave a public hospital emergency department without being seen by a physician. Causes and consequences. JAMA (1991) 3.92

Explaining variations in hospital death rates. Randomness, severity of illness, quality of care. JAMA (1990) 3.90

Measuring underuse of necessary care among elderly Medicare beneficiaries using inpatient and outpatient claims. JAMA (2000) 3.89

Health care for black and poor hospitalized Medicare patients. JAMA (1994) 3.74

The appropriateness of carotid endarterectomy. N Engl J Med (1988) 3.66

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest (1998) 3.66

Differences in CAHPS adult survey reports and ratings by race and ethnicity: an analysis of the National CAHPS benchmarking data 1.0. Health Serv Res (2001) 3.62

Adjusted hospital death rates: a potential screen for quality of medical care. Am J Public Health (1987) 3.52

A health-related quality of life measure for multiple sclerosis. Qual Life Res (1995) 3.46

A comparative review of generic quality-of-life instruments. Pharmacoeconomics (2000) 3.42

Does inappropriate use explain small-area variations in the use of health care services? JAMA (1990) 3.38

Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. J Behav Med (1992) 3.38

Development of a brief screening instrument for detecting depressive disorders. Med Care (1988) 3.37

Why do symptomatic patients delay obtaining care for tuberculosis? Am J Respir Crit Care Med (1998) 3.30

Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med (1991) 3.25

The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25

Overview of adult health measures fielded in Rand's health insurance study. Med Care (1979) 3.20

Audit of coronary angiography and bypass surgery. Lancet (1990) 3.17

Termination of Medi-Cal benefits. A follow-up study one year later. N Engl J Med (1986) 3.16

Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA (2000) 3.13

Do physicians preach what they practice? A study of physicians' health habits and counseling practices. JAMA (1984) 3.05

Regular source of ambulatory care and medical care utilization by patients presenting to a public hospital emergency department. JAMA (1994) 3.05

Patterns of care related to age of breast cancer patients. JAMA (1987) 2.92

The appropriateness of performing coronary artery bypass surgery. JAMA (1988) 2.92

Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study. JAMA (1989) 2.79

Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res (1997) 2.75

Use of medical care in the Rand Health Insurance Experiment. Diagnosis- and service-specific analyses in a randomized controlled trial. Med Care (1986) 2.70

Racial and ethnic differences in parents' assessments of pediatric care in Medicaid managed care. Health Serv Res (2001) 2.68

Prospective payment system and impairment at discharge. The 'quicker-and-sicker' story revisited. JAMA (1990) 2.66

Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst (2000) 2.66

Inappropriate use of hospitals in a randomized trial of health insurance plans. N Engl J Med (1986) 2.65

Managed care and capitation in California: how do physicians at financial risk control their own utilization? Ann Intern Med (1995) 2.64

Physician ratings of appropriate indications for three procedures: theoretical indications vs indications used in practice. Am J Public Health (1989) 2.63

Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package. JAMA (1995) 2.62

Does fear of immigration authorities deter tuberculosis patients from seeking care? West J Med (1994) 2.61

Choosing measures of health status for individuals in general populations. Am J Public Health (1981) 2.60

Can health care quality indicators be transferred between countries? Qual Saf Health Care (2003) 2.58

Group judgments of appropriateness: the effect of panel composition. Qual Assur Health Care (1992) 2.56

Appropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access endoscopy unit. Endoscopy (1996) 2.55

The cost effectiveness of preoperative autologous blood donations. N Engl J Med (1995) 2.49

Physician and patient satisfaction as factors related to the organization of internal medicine group practices. Med Care (1985) 2.47

Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system. JAMA (1990) 2.47

Changing physician payment for Medicare patients. Projected effects on the quality of care. West J Med (1986) 2.46

Persuasive communication and medical technology assessment. Arch Intern Med (1985) 2.41

Self-study from web-based and printed guideline materials. A randomized, controlled trial among resident physicians. Ann Intern Med (2000) 2.40

Quality of life of African-American and white long term breast carcinoma survivors. Cancer (1999) 2.39

Health status, job satisfaction, job stress, and life satisfaction among academic and clinical faculty. JAMA (1985) 2.37

Format and conduct of consensus development conferences. Multi-nation comparison. Int J Technol Assess Health Care (1990) 2.36

Arm edema in breast cancer patients. J Natl Cancer Inst (2001) 2.35

Watching the doctor-watchers. How well do peer review organization methods detect hospital care quality problems? JAMA (1992) 2.34

Changes in sickness at admission following the introduction of the prospective payment system. JAMA (1990) 2.33

Efficacy, effectiveness, variations, and quality. Boundary-crossing research. Med Care (1985) 2.32